Cover Image
Market Research Report

Asia Pacific Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type, By Product, Application, and Geography

Published by The Insight Partners Product code 928779
Published Content info 155 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type, By Product, Application, and Geography
Published: February 21, 2020 Content info: 155 Pages
Description

The Asia Pacific cell line development market is expected to reach US$ 2,813.78 Mn in 2027 from US$ 987.48 Mn in 2019. The market is estimated to grow with a CAGR of 14.0% from 2020-2027.

The growth of the cell line development market is primarily attributed to the increasing foreign direct investments in these countries, highly skilled, efficient, and a large number of human resources, streamlining government policies resulting in high expenditures for the biotechnology sector.

In the last few years, stem cell research became a significant field in the Asia Pacific medical sector, experiencing good development vision for the treatment of some challenging diseases. The government of the country organized various awareness programs for stem cell research. Moreover, the growing number of players operating across the country manufactures products for cell line development. The countries such as Australia, India, and South Korea are estimated to serve various growth opportunities due to the rising development in the biotechnology sector.

Moreover, the companies are performing various activities for the cell line development market, for instance, Selexis, Carestream Avacta, JSR Life Sciences. Has done recent developments for products.

In 2018, the recombinant cell line segment held the most significant market share of the cell line development market, by type. This segment is also anticipated to dominate the market in 2027 owing to its popularity among manufacturers for the production of therapeutic recombinant proteins. The hybridomas segment is anticipated to witness growth at a significant rate during the forecast period.

The Japan cell line development market is dominated by intraoral media and reagent segment in 2019 with a considerable market share, by product. This segment is also predicted to dominate the market in 2027. Also, media and reagent segment is anticipated to witness growth at a significant rate during the forecast period, owing to the increasing research activities in biotechnology sector.

In 2019, the Bioproduction segment held a considerable market of the cell line development market, by the application. This segment is also predicted to dominate the market in 2027 owing to higher demand of biologics. However, the drug discovery segment is anticipated to witness growth at a significant rate during the forecast period.

Some of the major primary and secondary sources for cell line development included in the report are Chinese Academy of Sciences, Council of Scientific and Industrial Research, and others.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific cell line development market market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00009031

Table of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance

2. Asia Pacific Cell Line Development Market - Key Takeaways

3. Asia Pacific Cell Line Development Market - Market Landscape

  • 3.1 Overview
  • 3.2 Market Segmentation
    • 3.2.1 Asia Pacific Cell Line Development Market - By Type
    • 3.2.2 Asia Pacific Cell Line Development Market - By Product
    • 3.2.3 Asia Pacific Cell Line Development Market - By Application
    • 3.2.4 Asia Pacific Cell Line Development Market - By Country
  • 3.3 PEST Analysis
    • 3.3.1 Asia Pacific - PEST Analysis

4. Asia Pacific Cell Line Development Market- Key Market Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Evolving Biopharma Sector in the Asia Pacific
    • 4.1.2 Rising Incidence of Chronic Diseases
  • 4.2 Key Market Restraints
    • 4.2.1 Risk Associated with Cell Line Contamination
  • 4.3 Key Market Opportunities
    • 4.3.1 Emerging Markets in the region
  • 4.4 future Trends
    • 4.4.1 Consistent Research in Drug Discovery Activities
  • 4.5 Impact analysis

5. Cell Line Development Market - Asia Pacific Analysis

  • 5.1 Asia Pacific Cell Line Development Market Revenue Forecasts and Analysis
  • 5.2 Market positioning
  • 5.3 Performance of Key Players
    • 5.3.1 Merck KGaA
    • 5.3.2 Thermo Fisher Scientific Inc.
  • 5.4 Expert Opinions

6. Asia Pacific Cell Line Development Market Analysis - By Type

  • 6.1 Overview
  • 6.2 Asia Pacific Cell Line Development Market, BY type, 2018 & 2027 (%)
  • 6.3 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By type (US$ Mn)
  • 6.4 Recombinant Cell Line Market
    • 6.4.1 Overview
    • 6.4.2 Asia Pacific Recombinant Cell Line Market Revenue And Forecasts To 2027(US$ Mn)
  • 6.5 Hybridomas
    • 6.5.1 Overview
    • 6.5.2 Asia Pacific Hybridoma Market Revenue And Forecasts To 2027 (US$ Mn)
  • 6.6 Primary Cell Line
    • 6.6.1 Overview
    • 6.6.2 Asia Pacific Primary Cell Line Market Revenue and Forecasts to 2027 (US$ Mn)
  • 6.7 Continuous Cell Lines
    • 6.7.1 Overview
    • 6.7.2 Asia Pacific Continuous Cell Lines Market Revenue and Forecasts to 2027 (US$ Mn)

7. Asia Pacific Cell Line Development Market Analysis - By Product

  • 7.1 Overview
  • 7.2 Asia Pacific Cell Line Development Market, BY product, 2018 & 2027 (%)
  • 7.3 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By product (US$ Mn)
  • 7.4 Media and Reagent Market
    • 7.4.1 Overview
    • 7.4.2 Asia Pacific Media and Reagent Market Revenue And Forecasts To 2027(US$ Mn)
  • 7.5 Equipment
    • 7.5.1 Overview
    • 7.5.2 Asia Pacific Equipment Market Revenue And Forecasts To 2027 (US$ Mn)

8. Asia Pacific Cell Line Development Market Analysis - By Application

  • 8.1 Overview
  • 8.2 Asia Pacific Cell Line Development Market, by Application, 2018 & 2027 (%)
  • 8.3 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 8.4 Bioproduction
    • 8.4.1 Overview
    • 8.4.2 Asia Pacific Bioproduction Market Revenue And Forecasts To 2027(US$ Mn)
  • 8.5 Drug Discovery
    • 8.5.1 Overview
    • 8.5.2 Asia Pacific Drug Discovery Market Revenue And Forecasts To 2027 (US$ Mn)
  • 8.6 Tissue Engineering
    • 8.6.1 Overview
    • 8.6.2 Asia Pacific Tissue Engineering Market Revenue And Forecasts To 2027 (US$ Mn)

9. Asia Pacific Cell Line Development Market Revenue and Forecasts to 2027

  • 9.1 Overview
  • 9.2 Asia Pacific Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.3 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By type (US$ Mn)
  • 9.4 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • 9.5 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 9.6 Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By Country (%)
  • 9.7 China Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.7.1 China Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.7.2 China Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.7.3 China Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 9.7.4 China Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 9.8 Japan Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.8.1 Japan Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.8.2 Japan Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.8.3 Japan Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 9.8.4 Japan Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 9.9 India Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.9.1 India Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.9.2 India Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.9.3 India Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 9.9.4 India Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 9.10 South Korea Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.10.1 South Korea Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.10.2 South Korea Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.10.3 South Korea Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 9.10.4 South Korea Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 9.11 Australia Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.11.1 Australia Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.11.2 Australia Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.11.3 Australia Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 9.11.4 Australia Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10. Cell Line Development Market -Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Cell Line Development Market, (%)
  • 10.3 Organic Developments
    • 10.3.1 Overview
    • 10.3.2 Organic Growth Strategies in the Cell Line Development Market, 2016-2019
    • 10.3.3 Expansion
      • 10.3.3.1 Recent Expansion By Players In The Cell Line Development Market
    • 10.3.4 Inorganic developments
    • 10.3.5 Overview
    • 10.3.6 Inorganic Growth Strategies In The Cell Line Development Market, 2016-2019
    • 10.3.7 Agreements
      • 10.3.7.1 The Cell Line Development Market, By Agreements
    • 10.3.8 Acquisitions
      • 10.3.8.1 Acquisitions By Players In The Cell Line Development Market
  • 10.4 Source: The Insight Partners Analysis

11. Cell Line Development Market-Key Company Profiles

  • 11.1 Merck KGaA
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Financial Overview
    • 11.1.4 Product Portfolio
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Thermo Fisher Scientific, Inc.
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Financial Information
    • 11.2.4 Product /Services Portfolio
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Sartorius AG
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Financial Overview
    • 11.3.4 Product Portfolio
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 SELEXIS
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Financial Overview
    • 11.4.4 Product/Service Portfolio
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 BioFactura, Inc.
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Financial Overview
    • 11.5.4 Product Portfolio
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 WuXi AppTec
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Financial Overview
    • 11.6.4 Service Portfolio
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 LakePharma, Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Financial Overview
    • 11.7.4 Product Portfolio
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 General Electric
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Financial Overview
    • 11.8.4 Product Portfolio
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Lonza
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Financial Information
    • 11.9.4 Product Portfolio
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Corning Incorporated
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Financial Overview
    • 11.10.4 Product Portfolio
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms
  • 12.3 Methodology
    • 12.3.1 Coverage
    • 12.3.2 Secondary Research
    • 12.3.3 Primary Research

LIST OF TABLES

  • Table 1. Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By type (US$ Mn)
  • Table 2. Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By product (US$ Mn)
  • Table 3. Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By Applicayion (US$ Mn)
  • Table 4. Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By type (US$ Mn)
  • Table 5. Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By product (US$ Mn)
  • Table 6. Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By application (US$ Mn)
  • Table 7. China Cell Line Development Market Revenue And Forecasts to 2027, By type (US$ Mn)
  • Table 8. China Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 9. China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 10. Japan Cell Line Development Market Revenue And Forecasts to 2027, By type (US$ Mn)
  • Table 11. Japan Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 12. Japan Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 13. India Cell Line Development Market Revenue And Forecasts to 2027, By type (US$ Mn)
  • Table 14. India Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 15. India Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 16. South Korea Cell Line Development Market Revenue And Forecasts to 2027, By type (US$ Mn)
  • Table 17. South Korea Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 18. South Korea Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 19. Australia Cell Line Development Market Revenue And Forecasts to 2027, By type (US$ Mn)
  • Table 20. Australia Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 21. Australia Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 22. Recent Expansion in the Cell Line Development Market
  • Table 23. the Cell Line Development Market by Agreements
  • Table 24. Acquisitions in the Cell Line Development Market
  • Table 25. Glossary of Terms, Cell Line Development Market

LIST OF FIGURES

  • Figure 1. Japan Cell Line Development Market, Revenue (US$ Mn), By 2018 & 2027
  • Figure 2. Asia Pacific Cell Line Development Market By type Market Share (%), 2018
  • Figure 3. Asia Pacific Cell Line Development Market By product Market Share (%), 2018
  • Figure 4. Asia Pacific Cell Line Development Market By application Market Share (%), 2018
  • Figure 5. Cell Line Development Market Segmentation
  • Figure 6. Asia Pacific PEST Analysis
  • Figure 7. Cell Line Development Market impact analysis of drivers & Restraints
  • Figure 8. Asia Pacific Cell Line Development Market - Revenue Forecasts and Analysis - 2018- 2027
  • Figure 9. Asia Pacific Cell Line Development Market, By type, 2018 & 2027 (%)
  • Figure 10. Asia Pacific recombinant cell line Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 11. Asia Pacific hybridoma Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 12. Asia Pacific Primary Cell Line Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 13. Asia Pacific Continuous Cell Lines Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 14. Asia Pacific Cell Line Development Market, By Product, 2018 & 2027 (%)
  • Figure 15. Asia Pacific Media and Reagent Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 16. Asia Pacific Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 17. Asia Pacific Cell Line Development Market, By Application, 2018 & 2027 (%)
  • Figure 18. Asia Pacific bioproduction Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 19. Asia Pacific Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 20. Asia Pacific Tissue Engineering Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. Asia Pacific Cell Line Development Market REVENUE, by Country, 2018 (US$ MN)
  • Figure 22. Asia Pacific Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 23. Asia Pacific Cell Line Development Market Revenue And Forecasts to 2027, By Country (%)
  • Figure 24. China Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 25. Japan Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 26. India Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 27. South Korea Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 28. Australia Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 29. Growth Strategies in the Cell Line Development Market, (%)
  • Figure 30. Organic Growth Strategies in the Cell Line Development Market, 2016-2019
  • Figure 31. Inorganic developments in the Cell Line Development Market, 2016-2019
Back to Top